Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ensysce Biosciences (ENSC) Other Operating Expenses (2020)

Ensysce Biosciences (ENSC) has disclosed Other Operating Expenses for 3 consecutive years, with $2.0 as the latest value for Q4 2023.

  • On a quarterly basis, Other Operating Expenses changed N/A to $2.0 in Q4 2023 year-over-year; TTM through Sep 2024 was $2.0, a 100.0% increase, with the full-year FY2019 number at $3.3 million, up 113.48% from a year prior.
  • Other Operating Expenses was $2.0 for Q4 2023 at Ensysce Biosciences, up from $1.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $1.3 million in Q4 2020 to a low of -$186458.0 in Q3 2022.
  • A 3-year average of $410822.3 and a median of $241418.5 in 2020 define the central range for Other Operating Expenses.
  • Biggest YoY gain for Other Operating Expenses was 100.0% in 2023; the steepest drop was 100.0% in 2023.
  • Ensysce Biosciences' Other Operating Expenses stood at $1.3 million in 2020, then crashed by 114.88% to -$186458.0 in 2022, then soared by 100.0% to $2.0 in 2023.
  • Per Business Quant, the three most recent readings for ENSC's Other Operating Expenses are $2.0 (Q4 2023), $1.0 (Q3 2023), and -$186458.0 (Q3 2022).